iSpecimen
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of iSpecimen generated cash of -$5,807,550, which is more than the previous year. Cash used in financing activities reached the amount of $70,889 last year. Net change in cash is therefore -$12,965,044.
Cash Flow
| 2018 | -2.68M | -1.02M | 3.51M |
|---|---|---|---|
| 2019 | -2.67M | -1.47M | 3.07M |
| 2020 | -288.38K | -1.10M | 2.03M |
| 2021 | -10.66M | -1.03M | 38.74M |
| 2022 | -5.81M | -3.19M | -3.42M |
| 2023 | -5.80M | -7.22M | 70.88K |
ISPC Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 15.30M | 27.73M | 695.90K | 53.89K | 1.13M | 1.32M |
Operating activities | ||||||
Net income | -11.09M | -10.24M | -8.96M | -4.65M | -4.72M | -5.34M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 2.11M | 1.20M | 1.00M | 819.68K | 634.96K | 469.17K |
Stock-based compensation expense | 459.66K | 678.61K | 622.06K | 92.86K | 360.37K | 0 |
| Deferred income tax benefit | 459.66K | 678.61K | 622.06K | 92.86K | 360.37K | 0 |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 820.61K | 1.29M | -1.63M | -800.90K | 192.25K | -393.19K |
Inventories | 0 | 0 | -2.46M | 1.91M | -7.62K | -12.66K |
Accounts payable | 1.46M | 1.62M | -959.75K | 1.05M | 40.88K | 584.05K |
Cash generated by operating activities | -5.80M | -5.81M | -10.66M | -288.38K | -2.67M | -2.68M |
Investing activities | ||||||
Purchases Of Investments | -13.03M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -19.47K | -3.19M | -1.03M | -1.10M | -1.47M | -1.02M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -7.22M | -3.19M | -1.03M | -1.10M | -1.47M | -1.02M |
Financing activities | ||||||
Common Stock Issued | 70.88K | 6.25K | 41.49M | 0 | 3.67K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -41 |
Repayments of term debt | 0 | -3.5M | -3M | -2.03M | 3.07M | 0 |
Cash used in financing activities | 70.88K | -3.42M | 38.74M | 2.03M | 3.07M | 3.51M |
Net Change In Cash | -12.96M | -12.43M | 27.04M | 642.01K | -1.07M | -192.08K |
Cash at end of period | 2.34M | 15.30M | 27.73M | 695.90K | 53.89K | 1.13M |
| Data source | Data source | Data source |